Report approved to revise regulations on imported goods
Anvisa approved the Regulatory Impact Analysis Report (RAIR) at its meeting on May 15. This is a crucial step in the revision of the Technical Regulation on goods and products imported for health surveillance, as established by RDC 81 of November 5, 2008.
If you need more information on regulatory issues, ELS can certainly help.
ontact your local ELS consultant or via email info@elssolutions.pt
ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.
Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.
Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.
